Launch of WHO antiretrovirals in pregnancy research toolkit
CHAIR
Elaine Abrams, Columbia University, United States
Organizer
Share
The WHO and the International Maternal Paediatric Adolescent AIDS Clinical Trials Network (IMPAACT) support greater inclusion of pregnant women and breastfeeding in clinical trials and call for all stakeholders to accelerate research in pregnancy for new HIV agents. During the satellite, WHO and IMPAACT will present a new toolkit for research in pregnancy and breastfeeding, that provides access to guidance, research documentation (e.g. protocols, case report forms, etc) and other resources relating to the inclusion of pregnant and breastfeeding women in clinical and research studies and surveillance programmes. The satellite is aimed at research networks, national HIV programmes, affected communities, innovator companies and regulatory agencies so that interested parties can openly access, use and adapt the resources to their needs and support optimal antiretroviral drug choices in pregnancy.
12:00
5 min
Including pregnant women in ARV research: No time to lose ! A new framework for accelerating the study of new drugs for HIV in pregnant and breastfeeding women
Columbia University, United States
12:05
15 min
Introducing the antiretrovirals in pregnancy research toolkit
WHO, Switzerland
Harvard T.H. Chan School of Public Health, United States
12:20
5 min
Putting this into practice through inclusive protocols
SHARE Collaborative Centre for Immunobiology, Blizard Institute Faculty of Medicine and Dentistry Queen Mary University of London, United Kingdom
12:25
5 min
Questions and answers
12:30
2 min
Panel introduction - How can we better use the tools we have to accelerate research during pregnancy?
WHO/HHS, Switzerland
EGPAF, United States
12:32
2 min
Protecting pregnant women through inclusion
University North Carolina, United States
12:34
2 min
The community perspective
4M, United Kingdom
12:36
2 min
Perspective from the industry
Gilead Sciences, United States
12:38
2 min
The regulatory authority perspective and guideline update
FDA, United States
12:40
15 min
12:40
15 min
Questions and answers
WHO/HHS, Switzerland
EGPAF, United States
University North Carolina, United States
4M, United Kingdom
FDA, United States
Gilead Sciences, United States
12:55
5 min
Closing remarks - From theory into practice
World Health Organaization, Switzerland